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Abstract
Objectives: Benign Oral Vascular Lesions (BOVLs) are a group of vascular diseases characterized by congenital, 
inflammatory or neoplastic vascular dilations clinically evidenced as more or less wide masses of commonly dark 
bluish color. If traumatized BOVLs are characterized by a great risk of hemorrhage and their treatment usually 
requires great caution to prevent massive bleeding. In the last decades lasers have dramatically changed the way 
of treatment of BOVLs permitting the application of even peculiar techniques that gave interesting advantages in 
their management reducing hemorrhage risks. The aim of this study was to evaluate the capabilities and disadvan-
tages of three laser assisted techniques in the management of BOVLs.
Study design: In this study 13 BOVLs were treated by three different laser techniques: the traditional excisional 
biopsy (EB), and two less invasive techniques, the transmucosal thermocoagulation (TMT) and the intralesional 
photocoagulation (ILP). Two different laser devices were adopted in the study: a KTP laser (DEKA, Florence, 
Italy, 532nm) and a GaAlAs laser (Laser Innovation, Castelgandolfo, Italy, 808nm) selected since their great ef-
fectiveness on hemoglobin.
Results: In each case, lasers permitted safe treatments of BOVLs without hemorrhages, both during the interven-
tion and in the post-operative period. The minimally invasive techniques (TMT and ILP) permitted even the safe 
resolution of big lesions without tissue loss.
Conclusions: Laser devices confirm to be the gold standard in BOVLs treatment, permitting even the introduction 
of minimal invasive surgery principles and reducing the risks of hemorrhage typical of these neoplasms. As usual 
in laser surgery, it is necessary a clear knowledge of the devices and of the laser-tissue interaction to optimize the 
results reducing risks and disadvantages.
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Introduction
The Benign Oral Vascular Lesions (BOVLs), are a group 
of common benign oral neoplasms including haeman-
giomas and vascular malformations. Vascular lesions 
often involve the skin and the mucous membranes, but 
they are also frequent in the mouth and tongue (1). The 
congenital variant of haemangiomas is often found in 
the labial mucosa.
Since their content rich in blood and vessels BOVLs are 
all characterized by high risk of hemorrhage and their 
treatment needs great attention if performed with tra-
ditional surgical techniques.  Recently, the use of laser 
energy as a therapeutic option offered a more conserva-
tive, but still effective, approach in their treatment (2). 
In the study, three different laser approaches of BOVLs 
are examined: excisional biopsy (EB), transmucosal 
thermocoagulation (TMT) and intralesional photoco-
agulation (ILP). 
The EB is based on the removal of the whole lesion 
through a peripheral incision. It is used for small le-
sions but it may be adopted also in large base lesions. 
Its disadvantages are mainly bleeding risks, possibility 
of scars formation especially in aesthetic areas but it is 
overall less invasive than other traditional blade tech-
niques determining less tissue loss.
The TMT is based on the laser irradiation without con-
tact of the fiber with the tissue. The preferable distance 
from the lesion surface is about 2-3mm. Energy must be 
applied with a scanning movement without keeping the 
fiber fixed on the same point for more than 5-10 seconds 
to avoid irreversible thermal effects. During the treat-
ment the lesion becomes lighter and smaller. This effect 
is called “forced dehydration” (3), and it is due to the high 
absorption of laser energy by the blood into the lesion. 
To a more safe execution of the TMT a transparent glass 
slide is put over the lesion to reduce lesion thickness and 
to facilitate the laser action. In case of larger lesions, 
more laser applications may be necessary. The advan-
tages of TMT are: no bleeding risk, no suture needed, 
bloodless operative field, relative facility and speed of 
execution, only surface and less invasive anesthesia. 
The possible necessity of multiple laser sessions and the 
impossibility of histological examination of the lesion 
are the main TMT disadvantages. TMT is really helpful 
if patients are affected by systemic pathologies such as 
factor VIII of coagulation deficiency. In these cases this 
no bleeding, safe and quick treatment permits a good 
resolution of the pathology without any risk, during and 
after the treatment. 
The ILP treatment is another minimally invasive proce-
dure (4). It allows the laser to release its energy directly 
into the lesions. The main risk related to the technique is 
that it is a “blind” procedure so a great attention must be 
dedicated to the exact extent of the lesion to minimize 
the risk of peripheral tissues damages. The real position 
of the fiber can be perceived by the transillumination 
produced by laser. This treatment is useful in deep and 
large lesions as vascular malformations of the tongue 
and big haemangiomas. 
In these cases the KTP laser is the most effective de-
vice because of its high specificity for the hemoglobin 
present in each of these lesions (5-8). Color changes, 
visible wrinkling and increased hardness of tissue are 
the signals of the end of the treatment. After the ILP 
treatment the application of ice over the treated area is 
helpful to prevent postoperative swelling. ILP therapy 
allows safe treatment of bulky vascular lesions that can-
not be treated by EB because of the danger of massive 
bleeding or for the treatment of lesions located in aes-
thetic areas that could create large unaesthetic scarring 
(5)  if removed by traditional methods. Even if ILP must 
be considered a generally safe technique, intraoperative 
bleeding risk and impossibility of histological examina-
tion are its main disadvantages. 
The aim of the study is to evaluate advantages and dis-
advantages of these techniques and compare their ways 
of action.
Material and Methods
Thirteen patients affected by BOVLs (Table 1) were 
treated using different laser techniques, by two laser 
devices: a KTP (DEKA, Florence, Italy, 532nm) and a 
diode GaAlAs (Laser Innovation, Castelgandolfo, Italy, 
808nm). These devices were selected because of their 
affinity to the oxyhaemoglobin that provokes a photo-
thermolysis, with erythrocytes microagglutination, that 
produces the vessels obliteration reducing hemorrhage 
risks. Moreover other advantages permitted by lasers 
are: reduced necessity of anesthesia, faster healing, 
more precise cutting, less postoperative discomfort due 
to the biostimulative effect.
Two cases were treated using an EB by a KTP (532nm) 
laser. The local anesthesia was performed without 
adrenaline, the choice of this kind of anesthesia is to 
avoid that the vasoconstriction induced by adrenaline 
may reduce the laser cut effectiveness. The lesion was 
immobilized by an Allis clamp and then the excision 
was performed by a circumferential cut at 1.2W power 
in continuous wave (Fig. 1). 
Eight of the patients were treated by the TMT technique 
with a KTP (532nm) laser set at 2.5W in continuous 
wave. After local surface anesthesia by lydocaine cream 
for 10 minutes, a thin glass was put over the lesion. The 
irradiation led to an ischemic area (Fig. 2).
A diode GaAlAs (808 nm) laser was used only in one of 
the TMT cases. It was set at 4W in continuous wave with 
a 320µ fiber. In this case a second laser application was 
performed to the complete dehydration of the lesion.  
The ILP treatment was adopted for the other three pa-
tients. In these cases the KTP (532nm) laser at 2W in 
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Fig. 1. Lesion immobilization by an Allis’ clamp and laser set at 
1.2W in CW (EB technique).
Fig. 2. Thin glass put over the lesion (TMT technique).
Fig. 3. The surface of the vascular lesion after the ILP tech-
nique. Laser irradiation at 2W in CW lead to an ischemic area 
(ILP technique).
CW was adopted. After surface lydocaine cream appli-
cation for 10 minutes, the fiber was put into the lesion 
provoking its collapse and carbonization (Fig. 3). The 
fiber was kept into the lesion until its breakdown.
After each treatment, it was asked the patients to evaluate 
the pain following a Numeric Rating Scale (NRS) in which 
a value corresponded to 0 indicated the absence of pain in-
stead of a value such as 10 corresponded to the higher and 
most intensive pain felt in the postoperative period.
Results
In every case, postoperative tissue sloughing occurred 
within few days. All the patients healed completely by 
re-epithelialization within 1 or 2 weeks. No patient re-
ferred postoperative bleeding or intensive pain (Table 
1). There were no infections, hematomas or damage to 
vital structures and ulcerations caused by the heat.
Recurrence happened only in a case in which a TMT 
technique was used. However, the patient was treated 
again with the same laser technique and same laser set-
tings and a complete healing was obtained.
Discussion
Maxillo-facial BOVLs are a wide group of pathologies 
including haemangiomas and vascular malformations 
(9). They are characterized by morphological, structur-
al and functional alterations of different nature, grav-
ity and extension and may involve every kind of vessel. 
More than 50% of BOVLs originates from blood vessels 
or vascular structures. They are frequently located in 
the head and neck region (8,10).
The right incidence in the population is unknown, 
even if a progressive increase during the last decades 
has been described. They are above all sporadic forms 
found in patients with a negative medical history. How-
ever, hereditary forms are described.
The incidence of haemangiomas is between 4-10% in chil-
dren. In the Tasnàdi series, amongst 3573 children aged 3 
years, the incidence of BOVLs was about 1.2% (5).
It is believed that BOVLs arise from two distinct path-
ways. The first one is the so-called primary vascular 
malformation. In such situation dysplastic blood vessels 
tend to drain into adjacent veins. The defect enlarges 
due to the increase of hydrostatic pressure. According 
to the second pathway a cavernous haemangioma is 
formed due to a faulty angiogenesis (a so-called biolog-
ic mechanism), which regresses with time (7).
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
Patient Sex Age
Systemic  
Diseases
Manifestation
and Clinical 
Appearance
Localization 
Histological  
Diagnosis 
Treatment Technique Recurrences 
Average
Pain 
S. A. m 78 Hypertension Vascular lesion Left cheek mucosa-area 2.6
GaAlAs laser at 3 
W in CW 
TMT 
No 2
L.R. m 77 Hemorrhagic 
petechiae
Soft palate KTP laser at 2 W 
in CW 
ILP No 2
R. S. m 70 Prostatic hypertrophy Vascular lesion Left cheek 
mucosa 
GaAlAs laser at 3 
W in CW 
TMT No 2
C.G. m 69 Hypertension, 
diabetes, high 
cholesterol,
previous brain 
hemorrhage 
Vascular lesion Tongue KTP laser at 2.5 
W in CW 
TMT No 3
C. S. m 66 Hypertension, 
hypercholesterole
mia 
Vascular lesion Tongue GaAlAs laser at 3 
W in CW 
TMT No 1
G.C. m 65 Hypertension, 
prostatic
hypertrophy, 
appendectomy, 
epitheliomas left 
ear and right leg 
Vascular lesion 
with a diameter 
of 0.6 cm sessile, 
fixed, soft, supple 
type 
Right cheek 
mucosa-area 
retrocom-
missural 
Shape rounded 
brownish color with 
a diameter of 0.6 
cm-diagnosis: 
inflammatory 
fibrous hyperplasia 
KTP laser at 2.5 
W in CW 
TMT No 1
S.G. m 58 Vascular lesion KTP laser at 2W 
in CW 
ILP No 2
S. A. m 52 Vascular lesion Lower lip GaAlAs laser at 3 
W in CW 
TMT No 2
D A. m 48 Hypertension, 
hypercholestero-
lemia thyroiditis 
Hioshimoto, 
myocardial 
infarction
Vascular lesion 
of 4 mm 
Half right 
lower lip 
KTP laser at 1.2 
W in CW 
EB No 1
C.L. m 24 Deficiency of 
coagulation
(factor VIII) 
Vascular lesion Half left 
palate-
molar area 
1) GaAlAs laser at  
4 W in CW with  
320 µ  fiber 
2) GaAlAs laser at 
4W in CW with 
320 µ  fiber 
1) TMT 
2) TMT 
1) Yes
2) No
1) 3 
2) 1 
A.S. f 74 Hypertension Vascular lesion Back of the 
tongue 
Fragment of 0.3 cm-  
diagnosis of 
capillary
hemangioma 
KTP laser at 1.2 
W in CW 
EB No 1
M.M. f 72 Vascular lesion Right cheek 
mucosa 
KTP laser at 2 W 
in CW 
ILP No 2
N. MS. f 48 Hyperglycemia, 
hiatal hernia, 
smoker 
Vascular lesion Right cheek 
mucosa 
GaAlAs laser at 3 
W in CW 
TMT No 1
Table 1. Table resuming patients, kind of lesion and laser treatment.
The tumors of blood vessels are a wide group of dis-
eases and they can be divided in benign, malignant and 
intermediate. Most of these tumors are the result of the 
differentiation of endothelial cells.
According to ISSVA (International Society for the 
Study of Vascular Anomalies) of 1992 vascular le-
sions may be classified in: tumors and malformations 
(Table 2).
In the Literature many other classifications are in use as 
the Mulliken and Glowacki’s one that is based on cellu-
lar criteria. In this sense BOVLs are subdivided in those 
ones characterized by endothelial proliferation (hae-
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Tumors Malformations
Angioma Capillary
Pyogenic Granuloma Venous
R. I. C. H. (rapidly involuting 
congenital hemangioma)
Arteriovenous
N. I. C. H. (noninvoluting 
congenital hemangioma)
Lymphatic
Angioblastoma Complex
Kaposiform Hemangioendo-
thelioma
Systemic
Table 2. Classification of BOVLs.
mangiomas) and in those ones with normal endothelial 
turnover (vascular malformations) (11).
The diagnosis of BOVLs is generally based upon sev-
eral clinical items: color, site, surface, margins, consist-
ence and size.
Haemangiomas are benign tumors of the capillary en-
dothelium very frequent in children. With respect to 
gender, the literature shows a higher incidence in girls 
(12-14). They grow quickly during the first weeks of 
life, but their size remains the same until the age of 12-
18 months. Usually they spontaneously diminish in size 
and their complete self-resolution at the age of 5 years 
is frequent (15,16).  Haemangiomas may be located su-
perficially or deeply everywhere in the oral cavity, more 
often on the lips and less frequently in the tongue and 
buccal mucosa (12). They are usually solitary lesions 
(80%), while multiple lesions (more than three) are of-
ten associated to a systemic involvement. Clinically, 
haemangiomas appear as red patches with irregular but 
well lined edges. They have a firm, rubbery consistency 
(11); during the growing phase, high concentrations of 
type IV collagenase, VEGF, bFGF and urokinase may 
be histological evidences (17). Haemangiomas compli-
cations are necrosis, ulcerations, infections and hemor-
rhages due to high blood content. In case of large lesions 
they can also cause difficulty in breathing, in chewing 
and in speech (12).
Venous and capillary-venous malformations are usually 
present at birth and grow contemporarily to the child. 
They are cold and soft and easily compressible (18-21). 
The overlying mucosa may show a bluish color. Venous 
malformations are usually solitary lesions. They may 
expand after local trauma or hormonal changes. Adja-
cent bony structures are often deformed and invasion of 
adjacent muscles is common (11).  
Arterio-venous malformations are uncommon on the 
head and neck region. They are evident early after birth 
and grow slowly with outbreaks linked to hormonal or 
mechanical factors. They have similar clinical features 
to the ones observed in port-wine stains, but in these 
cases the overlying skin is warmer (22-24). Clinically 
they appear as swellings with different dimensions 
and extension. A biphasic clinical course is typical. An 
asymptomatic phase is generally followed by a growing 
one. During the latter, ulcers of the overlying skin and 
hemorrhage may occur and adjacent bony structures 
may be necrotized (11).
Capillary malformations (port-wine stains) are often 
located in the territory of the branches of the trigemi-
nal nerve. They are characterized by the presence of a 
thick system of venules and post-capillaries abnormally 
dilated. Usually, they do not undergo spontaneous in-
volution like haemangiomas (18,19). Clinically they ap-
pear as pink or red-purple mucous patches, with clear 
or jagged margins. Their dimension and extensions are 
variable. They may be solitary, multiple or confluent. 
Skeletal hypertrophy and hyperkeratinisation of the 
overlying skin are common in large lesions. Capillary 
malformations may be found in association with gener-
alized angiomatosis, such as Sturge–Weber syndrome 
(11). Furthermore, typical of these lesions is the locali-
zation only by one side of the body.
Digital pressure applied over every BOVLs induces 
ischaemia to the overlying mucosa; this evidence is 
pathognomonic of the vascular origin of the lesion.
Regarding treatment, corticosteroids have been used to 
reduce the size of the lesion (11,13), embolization, and 
intralesional injections of sclerosing agents (25). Ac-
cording to McHeik et al. (13), intralesional injection of 
corticosteroids may produce ulceration of the lesion. 
These same authors obtained very good results with 
surgical treatment of haemangiomas at an early age in 
cases with aesthetic problems or complications such 
as ulceration, pain, bleeding and infection. In a study 
of Minguez-Sanz et al., 13 were surgically removed, 2 
were treated by embolization, and 13 disappeared spon-
taneously. Most congenital haemangiomas in this study 
regressed spontaneously without requiring treatment.
In the last decades lasers greatly enhanced both treat-
ment and prognosis of BOVLs; these devices may avoid 
many complications related to these pathologies, in par-
ticular as the hemorrhages, typical of the conventional 
surgery. Laser allows an easy removal, even if its use is 
not safe in arterial lesions. In these latter the emboliza-
tion of the main artery is mandatory.
The interaction between laser and tissue is due to the 
energy absorbed by tissues. For the correct treatment 
of a lesion with high blood content it is necessary to 
choose a laser emitting in a wavelength well absorbed 
by haemoglobin. KTP, diode, Nd:YAG and CO2 are the 
most effective wavelengths in these cases (4,23,26).
Moreover for a correct laser treatment of BOVLs it is 
necessary to well evaluate many further parameters as: 
pulse duration, spot size and the energy density. The 
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choice of the pulse duration should be done according 
to the size of the vessels to be treated. Shorter pulse du-
rations are preferable for small diameter vessels while 
longer pulse durations must be employed in larger di-
ameter ones. The spot size selection should be based ac-
cording to the depth and the size of the lesion. Finally, 
the selection of the energy density should be based on 
the color of the lesion, purple and bluish lesions absorb 
laser energy more than pink or red ones requiring for 
this reason lower fluencies (2). 
According to our experience it is possible to affirm that 
lasers are the gold standards in the treatment of BOVLs 
of the oral cavity with venous flow. The EB, the sole 
to permit a histological diagnosis of the lesion must be 
reserved to vascular lesions suspected to be malignant 
neoplasms. 
Amongst the laser techniques the TMT seems to be the 
most reliable and advantageous. In fact, in TMT the 
optical fiber is not in contact with the lesion, resulting 
so absolutely safe and sure even in patients affected by 
systemic diseases as coagulation problems or in antico-
agulant therapies. 
 This method permits also good functional and aesthetic 
results and it gives poor or no intra- and postoperative 
complications. Its sole contraindication is the impossi-
bility to perform the histological examination. 
The ILP is often used for wide and deeper lesions that can-
not be treated with TMT. ILP is characterized by a higher 
risk of bleeding due to the fiber penetration into the lesion, 
but it can be overall considered a safe technique.
It is possible to assess that laser treatment of BOVLs is 
safe and effective, and in many cases it represents the 
gold standard technique permitting results unattainable 
with conventional treatments.
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